Elizabeth Murphy Lilly - Jun 21, 2023 Form 4 Insider Report for APOGEE ENTERPRISES, INC. (APOG)

Role
Director
Signature
/s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly
Stock symbol
APOG
Transactions as of
Jun 21, 2023
Transactions value $
$0
Form type
4
Date filed
6/22/2023, 06:51 PM
Previous filing
Jun 23, 2022
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APOG Common Stock Award $0 +602 +5.06% $0.00 12.5K Jun 21, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APOG Deferred Restricted Stock Units Award $0 +1.81K $0.00 1.81K Jun 21, 2023 Common Stock 1.81K $0.00 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares vest over a three year vesting period with one-third of the shares vesting on each anniversary of the award.
F2 Includes restricted stock awards under the 2019 Non-Employee Director Stock Plan.
F3 Settled 1-for-1.
F4 The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.